547
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of rat liver cathepsins B and L by the peptide aldehyde benzyloxycarbonyl-leucyl-leucyl-leucinal and its analogues

, , &
Pages 279-286 | Received 02 Aug 2007, Accepted 17 Mar 2008, Published online: 01 Feb 2009

Figures & data

Figure 1.  Synthetic procedures of ZLLLal and Its analogues. Synthetic procedures of Lsc(TosOH) (a), ZLLLal (b) and FuLLLal (c) are schematically shown. DIBAL, diisobutylaluminum hydride; Pd/C, activated palladium/charcoal; N2H4 H2O, hydrazine hydrate; HOBt, 1-hydroxybenzotriazole; DCC, dicyclohexylcarbodiimide.

Figure 1.  Synthetic procedures of ZLLLal and Its analogues. Synthetic procedures of Lsc(TosOH) (a), ZLLLal (b) and FuLLLal (c) are schematically shown. DIBAL, diisobutylaluminum hydride; Pd/C, activated palladium/charcoal; N2H4 H2O, hydrazine hydrate; HOBt, 1-hydroxybenzotriazole; DCC, dicyclohexylcarbodiimide.

Table I.  Structures of ZLLLal and its analogues synthesized in this study.

Table II.  Physico-chemical properties of ZLLLal and its analogues.

Figure 2.  Inhibition of rat liver cathepsin B by ZLLLal and its analogues. The curve fitting was performed using GraFit 4.0 for determination of IC50 values [15].

Figure 2.  Inhibition of rat liver cathepsin B by ZLLLal and its analogues. The curve fitting was performed using GraFit 4.0 for determination of IC50 values [15].

Table III.  IC50 values for the inhibition of cathepsins B and L with ZLLLal and its analogues. The IC50 values were obtained from and using GraFit 4.0 for determination of IC50 values [Citation15].

Figure 3.  Inhibition of rat liver cathepsin L by ZLLLal and its analogues. The curve fitting was performed using GraFit 4.0 for determination of IC50 values [15].

Figure 3.  Inhibition of rat liver cathepsin L by ZLLLal and its analogues. The curve fitting was performed using GraFit 4.0 for determination of IC50 values [15].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.